At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.
With a team of approximately 7,500 employees – more...and operations in more than 40 countries, we are a global biopharmaceutical company investing more than a quarter of our revenue in cutting-edge scientific research. We are focused on addressing chronic, neurological, immunological, and bone diseases.
Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?” And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.
UCB – The Facts
• 7500 people in 40 countries, with over 70 nationalities
• 49% women, 51% men
• Total revenue grew to €4.6 billion in 2018
• ~25% of revenue invested in R&D
Discover more about our culture or explore your next opportunity at www.ucb.careers.com – less
What are people saying about the leadership at UCB?
of employees approve of CEO’s performance
CEO Approval is based on 108 ratings
Great company in general, let down by a few bad apples
Written by IT Manager (Former Employee) from Belgium on 16 January 2018
Whilst there are some extremely dedicated and professional employees, In the IT Dept - there are some less than savoury characters in management positions - which have been allowed manage their teams with intimidation and a certain level of maliciousness.
The company does have a great focus on Patients and bringing solutions and cures that can significantly - more...
Good employment package
Weak senior management and HR functions, for dealing with rogue managers